VOTING AGREEMENT among: MADRIGAL PHARMACEUTICALS, INC., a Delaware corporation; SYNTA PHARMACEUTICALS CORP., a Delaware corporation; and the undersigned StockholderVoting Agreement • April 14th, 2016 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
THIS VOTING AGREEMENT (“Agreement”), dated as of April [·], 2016, is made by and among Synta Pharmaceuticals Corp., a Delaware corporation (“Synta”), Madrigal Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.
LOCK-UP AGREEMENTLock-Up Agreement • April 14th, 2016 • Synta Pharmaceuticals Corp • Pharmaceutical preparations
In connection with the proposed acquisition of Madrigal Pharmaceuticals, Inc. (the “Company”) by Synta Pharmaceuticals Corp. (“Synta”) whereby Saffron Merger Sub, Inc. (“Merger Sub”), a wholly-owned subsidiary of Synta, will merge with and into the Company (the “Merger”), and in consideration of Synta, Merger Sub and the Company entering into the Agreement and Plan of Merger and Reorganization dated on or about April [•], 2016 (the “Merger Agreement;” all capitalized terms used in this Lock-Up Agreement without definition herein shall have the meanings ascribed to them in the Merger Agreement), the receipt and sufficiency of such consideration being hereby acknowledged and accepted, and in order to induce Synta and the Company each to close the Merger, the undersigned (“Securityholder”), a holder of shares of Company Capital Stock and/or Convertible Debt (the “Company Securities”) who will receive shares of Saffron Common Stock in exchange for his, her or its shares of Company Securiti
